Number of Shares
916.00
Current Holdings Value*
€69,310.00
% of Portfolio
1.84%
Total Estimate Gain
€-29,941.43
% of Total Estimate Gain
-40.02%

Amplify Weight Loss Drug & Treatment ETF's Gerresheimer AG Holding Summary

As of 2025-03-31, Amplify Weight Loss Drug & Treatment ETF held 916.00 shares of Gerresheimer AG(XTER:GXI), totaling €69,310.00. This investment constitutes 1.84% of their stock portfolio, and Amplify Weight Loss Drug & Treatment ETF now holds 0% of the outstanding Gerresheimer AG(XTER:GXI) stock.

The initial trade took place in 2024Q2. And since then Amplify Weight Loss Drug & Treatment ETF has made 3 purchases of XTER:GXI, at an average price of €81.69, for a total of 916.00 shares. Based on historical transaction data and XTER:GXI's current price of €49.00, Amplify Weight Loss Drug & Treatment ETF's estimated gain on his XTER:GXI holdings is €-29,941.43, reflecting a -40.02% gain to date.

Amplify Weight Loss Drug & Treatment ETF XTER:GXI (€49.00) Holding Chart

Amplify Weight Loss Drug & Treatment ETF XTER:GXI (€49.00) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price €-/Share
Shares Sold 0 Average Price €-/Share
Current Price €0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1